Varamir
sign in

QNCX

Quince Therapeutics, Inc.
26.87post−$0.54 (−1.97%)at close +$0.00 (+0.00%)
tap the star to start your desk
as of 20:10:43 UTCnext report Aug 10 · 5d
Earnings Room‹ back to QNCX

The report

fiscal Q2 2026 · from the company's notice
Aug 10after close5days out

Expected movement

market-implied · at the Aug 4 close
±22.9%is what the chain prices between now and the expiry below. Not a view we hold.

That span is 73days, so it covers the report plus the ordinary movement around it. The chain doesn't yet quote a second expiry we can separate the two with; the range narrows onto the report as it approaches.

expiry Oct 16 · first after the reportATM strike 7.5straddle 7.23ATM IV 134%× 0.85 straddle-to-rangespot 26.87

Blast radius

who else moves

No funds hold this name and no filing names it as a supplier or customer, so there is nothing for a move to travel along yet.

Positioning

Butterfly Ladder

No options positioning captured for this ticker yet. Open interest settles once daily — check back after the next capture, or open this room again tomorrow.

The record

the session each report moved

The stamp starts filling with the next report we price. It pairs the move the options market expected with the move the stock actually made, so the multiple between them accumulates into this company's own record. Nothing is back-filled from figures we didn't observe.

2-quarter memory
Q1 FY26 · reported 2.88 · rev $0
record note

The note composes when the report lands. Nothing is written for a quarter that hasn't been read.